Evidence map›Paper›PMID 35759735›Full record

ArticleHealth affairs (Project Hope)2022

The Diabetes Prevention Gap And Opportunities To Increase Participation In Effective Interventions.

Maria L Alva, Rosette J Chakkalakal, Tannaz Moin, Karla I Galaviz

Open access · greenAbstract read
In one paragraph

Article in Health affairs (Project Hope), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Managing Patient Demand in a Value-Based System.Annals of family medicine · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Maria L AlvaMaria L. Alva (mla72@georgetown.edu), Georgetown University, Washington, D.C.
Rosette J ChakkalakalRosette J. Chakkalakal, Emory University, Atlanta, Georgia.
Tannaz MoinTannaz Moin, University of California Los Angeles, Irvine, California.
Karla I GalavizKarla I. Galaviz, Indiana University, Bloomington, Indiana.
Emory University · USGeorgetown University · USIndiana University Bloomington · USUniversity of California, Irvine · US

Funding

Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention ProgramR01DK120814 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHAKKALAKAL, ROSETTE J · 2019 to 2023
$2.5M
The UC DPP Study: Evaluating a Diabetes Prevention Initiative Across the University of California SystemR01DK124503 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MOIN, TANNAZ · 2020 to 2023
$2.0M
Cost-effectiveness of cardiovascular disease prevention in HIV care: a systems science approachK01HL149479 · NHLBI · TRUSTEES OF INDIANA UNIVERSITY · PI GALAVIZ, KARLA IVETTE · 2019 to 2023
$638k
NHLBI NIH HHS K01 HL149479NIDDK NIH HHS R01 DK120814NIDDK NIH HHS R01 DK124503
6 · The paper itself

Abstract

To understand the current state of prediabetes burden and treatment in the US, we examined recent trends in prediabetes prevalence, testing, and access to preventive resources. We estimated 13.5 percent prevalence of diagnosed prediabetes in the overall US adult population, using national survey data. Although prediabetes prevalence increased by 4.8 percentage points from 2010 to 2020, access to preventive resources remained low. The most effective intervention for diabetes prevention, known as the National Diabetes Prevention Program, remained woefully undersupplied and underused. There are only 2,098 National Diabetes Prevention Program-recognized providers nationally, and only 3 percent of adults with prediabetes have participated in the program. We suggest three actions to augment prevention efforts: increase payment for prevention interventions to avoid supply distortions, improve data integration and patient follow-up, and extend coverage and broaden access for preventive interventions. These actions, which would require policy-level changes, could lower the barriers to prevention.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateAdultHumansPrevalence

Identifiers

PMID35759735
PMCPMC10112939
OpenAlexW4283696455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.